Evidence map›Paper›PMID 41524535›Full record

ArticleeLife2026

Predicting the effect of CRISPR-Cas9-based epigenome editing.

Sanjit Singh Batra, Alan Cabrera, Jeffrey P Spence, Jacob Goell, Selvalakshmi S Anand, Isaac B Hilton, Yun S Song

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Clinical translation of epigenome editing technologies.Current opinion in biomedical engineering · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sanjit Singh Batra *Computer Science Division, University of California, Berkeley, United States.
Alan Cabrera *Department of Bioengineering, Rice University, Houston, United States.
Jeffrey P Spence *Department of Genetics, Stanford University, Stanford, United States.ORCID 0000-0002-3199-1447
Jacob GoellDepartment of Bioengineering, Rice University, Houston, United States.
Selvalakshmi S AnandSystems, Synthetic, and Physical Biology Graduate Program, Rice University, Houston, United States.ORCID 0009-0000-4436-2618
Isaac B HiltonDepartment of Bioengineering, Rice University, Houston, United States.ORCID 0000-0002-3064-8532
Yun S SongComputer Science Division, University of California, Berkeley, United States.ORCID 0000-0002-0734-9868

Funding

Robust and efficient statistical inference methods for genomicsR35GM134922 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SONG, YUN S · 2020 to 2024
$2.0M
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights (R35GM143532)R35GM143532 · NIGMS · RICE UNIVERSITY · PI HILTON, ISAAC · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM134922NIGMS NIH HHS R35-GM134922NIGMS NIH HHS R35 GM143532NIGMS NIH HHS R35-GM143532
6 · The paper itself

Abstract

Epigenetic regulation orchestrates mammalian transcription, but functional links between them remain elusive. To tackle this problem, we use epigenomic and transcriptomic data from 13 ENCODE cell types to train machine learning models to predict gene expression from histone post-translational modifications (PTMs), achieving transcriptome-wide correlations of ∼0.70-0.79 for most cell types. Our models recapitulate known associations between histone PTMs and expression patterns, including predicting that acetylation of histone subunit H3 lysine residue 27 (H3K27ac) near the transcription start site (TSS) significantly increases expression levels. To validate this prediction experimentally and investigate how natural vs. engineered deposition of H3K27ac might differentially affect expression, we apply the synthetic dCas9-p300 histone acetyltransferase system to 8 genes in the HEK293T cell line and to 5 genes in the K562 cell line. Further, to facilitate model building, we perform MNase-seq to map genome-wide nucleosome occupancy levels in HEK293T. We observe that our models perform well in accurately ranking relative fold-changes among genes in response to the dCas9-p300 system; however, their ability to rank fold-changes within individual genes is noticeably diminished compared to predicting expression across cell types from their native epigenetic signatures. Our findings highlight the need for more comprehensive genome-scale epigenome editing datasets, better understanding of the actual modifications made by epigenome editing tools, and improved causal models that transfer better from endogenous cellular measurements to perturbation experiments. Together, these improvements would facilitate the ability to understand and predictably control the dynamic human epigenome with consequences for human health.

Indexed as

CRISPR-Cas SystemsEpigenesis, GeneticEpigenome EditingEpigenomicsHEK293 CellsHistonesHumansK562 CellsMachine LearningPredictive Learning ModelsProtein Processing, Post-TranslationalHistonescomputational biologygene expressionhumanmachine learningnucleosome occupancyperturbationpost-translational modificationssystems biology

Identifiers

PMID41524535
PMCPMC12795505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.